Complexities related to the amorphous content of lactose carriers

Int J Pharm X. 2023 Oct 23:6:100216. doi: 10.1016/j.ijpx.2023.100216. eCollection 2023 Dec 15.

Abstract

Although the amount of amorphous content in lactose is low, its impact on the performance of a dry powder inhalation formulation might be high. Many formulators and regulatory agencies believe that the levels of amorphous content should be controlled once there is a relationship with the final product performance. This is however not an easy task. The current paper elaborates on multiple challenges and complexities that are related to the control of the amorphous content in lactose. The definition and quantification methods of amorphous lactose are reviewed, as well as challenges related to thermodynamic instability. Additionally, current monographs and recent position papers considering this parameter are discussed to provide an overview of the regulatory landscape. Development of a control strategy is recommended, provided that the amorphous content at a specific moment in the process has shown to have an impact on the performance of the dry powder inhaler.

Keywords: Amorphous content; Control strategy; Dry powder inhalation; Interaction forces; Lactose; Physical characterization; Polymorphic form.

Publication types

  • Review